Please Wait

Applying Filters...

Looking for Pharmaceutical Excipients offered by Bioplus Life Sciences? Find disodium [4-[pyridin-2-yl-(4-sulfonatooxyphenyl)methyl]phenyl] sulfate to address your drug delivery challenges on PharmaCompass.

disodium [4-[pyridin-2-yl-(4-sulfonatooxyphenyl)methyl]phenyl] sulfate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 3 USDMF, 3 CEP/COS, 4 JDMF, 4 EU WC, 4 NDC API, 19 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

24 FDF Dossiers, 4 FDA Orange Book, 12 Europe, 3 Canada, 1 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 1 DKSH, 1 Pharm-RX Chemical, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Actylis, 1 Bioplus Life Sciences, 1 Pluviaendo

EXCIPIENTS BY APPLICATIONS

6 Taste Masking, 1 Parenteral

DIGITAL CONTENT

7 NEWS #PharmaBuzz

7 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 Finished Drug Prices, 1 Annual Reports

MARKET PLACE

14 APIs

14 APIs

PATENTS & EXCLUSIVITIES

5 US Patents

5 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 2 Others

$ Xls

Filters

Disodium [4-[pyridin-2-yl-(4-sulfonatooxyphenyl)methyl]phenyl] Sulfate

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Bioplus Life Sciences

filter Capability Reset all filters

filter Country Reset all filters

01

Bioplus Life Sciences

Pharmaconex 2024

Not Confirmed